Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
ESMO Gastrointestinal Oncology|February 6, 2026
Improving gastrointestinal cancer therapy by uniting stakeholdersM Quante, A Saborowski, C B Westphalen, et al.Innere Medizin (Heidelberg, Germany)|August 4, 2022
[Treatment of metastatic pancreatic cancer]V Heinemann, S Boeck, C B WestphalenAnnals of Oncology : Official Journal of the European Society for Medical Oncology|August 5, 2022
Cancer: slaying the nine-headed HydraJ J Adashek, V Subbiah, C B Westphalen, et al.Cancer Epidemiology|February 1, 2022
Age and metastasis - How age influences metastatic spread in cancer. Colorectal cancer as a modelE Pretzsch, H Nieß, F Bösch, et al.ESMO Gastrointestinal Oncology|February 6, 2026
Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignanciesL Weiss, D Zhang, W G Kunz, et al.NPJ Precision Oncology|July 21, 2021
Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world populationC B Westphalen, M G Krebs, C Le Tourneau, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2018
Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancerS Kruger, V Heinemann, C Ross, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 5, 2019
Neurotrophic tropomyosin receptor kinase (NTRK) and nerve growth factor (NGF) are not expressed in Caucasian patients with biliary tract cancers: pooled data from three independent cohortsC B Westphalen, A Preinfalk, S Kruger, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 20, 2021
Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxelL Sams, S Kruger, V Heinemann, et al.Journal of Cancer Research and Clinical Oncology|July 20, 2023
In-vitro model to mimic T cell subset change in human PDAC organoid co-cultureM Knoblauch, T Ma, I Beirith, et al.Pageof 4